Cyclin D1 and CDK6, as the other two important regulators in cell cycle and cell proliferation [30–32], have been demonstrated to be highly expressed in prostate cancer and have enormous potential in wide various of cancer research and prognosis judgement [33–36]. The gene discussed is CDK6; the disease is prostate carcinoma.